At Cliantha Research, we support the clinical development of biologics and biosimilars with end-to-end solutions across early- and late-phase trials. Our multidisciplinary teams combine therapeutic expertise, operational excellence, and advanced infrastructure to deliver high-quality, regulatory-compliant studies.

We have strong capabilities in managing complex biosimilar study designs, including PK/PD studies, immunogenicity assessments, comparative efficacy trials, and safety evaluations. Our integrated clinical, bioanalytical, and data management services ensure seamless execution aligned with global regulatory standards.

With specialized clinical units, advanced laboratories, and experienced investigators, we help sponsors navigate the scientific and operational challenges of biologic development, delivering robust biosimilarity and therapeutic comparability studies that accelerate the path to market.